Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study

Peer Review reports

Original Submission
24 Sep 2018	Submitted	Original manuscript
21 Nov 2018	Reviewed	Reviewer Report - Arjun Nambiar
23 Jan 2019	Reviewed	Reviewer Report - Kurt Naber
14 Feb 2019	Author responded	Author comments - Derick Wade
Resubmission - Version 2
14 Feb 2019	Submitted	Manuscript version 2
Publishing
1 Mar 2019	Editorially accepted
16 Apr 2019	Article published	10.1186/s13063-019-3275-x

Back to article page